Concepedia

Mahesh N. Samtani

MN

32

Publications

1.5K

Citations

24

H-Index

2004

Active since

Affiliations

Janssen (United States)(Current)

Johnson & Johnson (United States)

University at Buffalo, State University of New York

Janssen (Belgium)

Springhouse

Mahesh N. Samtani is an author at Janssen (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2004–2023

32

Publications

32

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia

Mahesh N. Samtani, An Vermeulen, Kim Stuyckens · Clinical Pharmacokinetics · 2009 · 166 citations

, , +7

The ADAS‐Cog revisited: Novel composite scales based on ADAS‐Cog to improve efficiency in MCI and early AD trials

Nandini Raghavan, Mahesh N. Samtani, Michael Farnum et al. · Alzheimer s & Dementia · 2012 · 94 citations · Full text

Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist <scp>JNJ</scp>‐64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose‐ranging study

Maria Alba, Jaqueline Yee, Mary Ellen Frustaci et al. · Clinical Obesity · 2021 · 87 citations

Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3‐month formulation in patients with schizophrenia: A phase‐1, single‐dose, randomized, open‐label study

Paulien Ravenstijn, Bart Remmerie, Adam Savitz et al. · The Journal of Clinical Pharmacology · 2015 · 84 citations

An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative

Mahesh N. Samtani, Michael Farnum, Victor S. Lobanov et al. · The Journal of Clinical Pharmacology · 2011 · 81 citations

Rows per page

1–5 of 32